Scribe Therapeutics, Inc. (SCTX) has 13 SEC Form 4 insider filings on record in the last 90 days. That includes 6 insider purchases totalling $71.3M. Most recent filing: July 29, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 29, 2026 filed July 27, 2026 | AH Bio Fund II, L.P. 10% Owner | +$4,999,995 | 19,364,072 | — | No | |
|
|
||||||
| July 29, 2026 filed July 23, 2026 | GORDON CARL L Director | +$15,000,000 | 3,414,497 | — | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | ORBIMED ADVISORS LLC Director | +$15,000,000 | 3,414,497 | — | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | Doudna Jennifer A 10% Owner | $0 | 86,599 | — | No | |
|
|
||||||
| July 28, 2026 filed July 24, 2026 | Aghazadeh Behzad Director | +$36,259,761 | 2,391,238 | +343% | No | |
|
|
||||||
Showing the 5 most recent of 13 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free